Jad Othman

Pretransplant <i>FLT3</i>-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome

Sun Loo, Richard Dillon, Adam Ivey et al. · Blood · 2022 · 83 citations · Full text

Pharmacy, Translational Sciences, Immunotherapy +2

Molecular, clinical, and therapeutic determinants of outcome in <i>NPM1</i>-mutated AML

Jad Othman, Nicola Potter, Adam Ivey et al. · Blood · 2024 · 79 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +11

Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study

Bruce Cartwright, Hannah M. Bruce, Geoffrey Kershaw et al. · Scientific Reports · 2021 · 78 citations · Full text

Medicine, Hematology, Surgery +17

Postinduction molecular MRD identifies patients with <i>NPM1</i> AML who benefit from allogeneic transplant in first remission

Jad Othman, Nicola Potter, Adam Ivey et al. · Blood · 2024 · 77 citations · Full text

Medicine, Molecular Medicine, Transplant Immunology +3

Molecular MRD is strongly prognostic in patients with <i>NPM1</i>-mutated AML receiving venetoclax-based nonintensive therapy

Jad Othman, Ing Soo Tiong, Jenny O’Nions et al. · Blood · 2023 · 65 citations · Full text

Medicine, Hematology, Oncology +14